Three months ended
September 30,

Nine months ended
September 30,

(in millions, except per share data)

2023

2022

2023

2022

Basic EPS

Net earnings attributable to AbbVie Inc.

$

1,778

$

3,949

$

4,041

$

9,363

Earnings allocated to participating securities

11

18

32

43

Earnings available to common shareholders

$

1,767

$

3,931

$

4,009

$

9,320

Weighted-average basic shares outstanding

1,767

1,771

1,768

1,771

Basic earnings per share attributable to AbbVie Inc.

$

1.00

$

2.22

$

2.27

$

5.26

Diluted EPS

Net earnings attributable to AbbVie Inc.

$

1,778

$

3,949

$

4,041

$

9,363

Earnings allocated to participating securities

11

18

32

43

Earnings available to common shareholders

$

1,767

$

3,931

$

4,009

$

9,320

Weighted-average shares of common stock outstanding

1,767

1,771

1,768

1,771

Effect of dilutive securities

4

5

4

6

Weighted-average diluted shares outstanding

1,771

1,776

1,772

1,777

Diluted earnings per share attributable to AbbVie Inc.

$

1.00

$

2.21

$

2.26

$

5.24